CLINICAL EFFICACY OF PYRIDOXINE AND MEFENAMIC ACID ALONE AND IN COMBINATION IN PREMENSTRUAL SYNDROME
Journal Title: International Journal of Medical and Clinical Research - Year 2012, Vol 3, Issue 2
Abstract
A wide range of drugs from different pharmacological groups have been tried in premenstrual syndrome by various investigators, with contradictory reports. Pyridoxine is reported to relieve autonomic and behavioural symptoms and NSAIDs to relieve physical symptoms. The present study evaluated and compared with placebo, the clinical efficacy of Pyridoxine and Mefenamic acid alone & in combination in relieving symptoms of pre-menstrual syndrome( PMS) Material/ Methods- 80 female patients between 18- 45 years of age, diagnosed to be suffering from PMS were randomly divided into 4 groups (A,B,C,D) of 20 patients each. They received Placebo tablets, Pyridoxine HCl 100 mg OD, Mefenamic acid 250 mg TDS and a combination of Pyridoxine and Mefenamic acid respectively for 7 days preceeding menstruation. Patients filled 36 item PMTS self rating scale and 22 item daily diary for 2 months before treatment to record baseline symptoms and during treatment cycle. 22 symptoms were divided into 4 subsets of physical, anxiety related, depression related and fluid- electrolyte related symptoms to study effect of drugs. Results- Statistically significant improvement from baseline symptoms occurred in patients receiving Pyridoxine, Mefenamic acid and their combination (group B,C, D), but mean %age improvement in all the 3 groups was not significantly different from Placebo (p>0.05). Significant (p<0.05) improvement in subset of physical symptoms occurred with mefenamic acid alone, but not with combination of pyridoxine and mefenamic acid. Conclusion- Placebo controll group must always be included in Premensrual syndrome trials. Mefenamic acid 250 mg TDS for 7 days preceeding menses relieved physical symptoms of PMS. However the beneficial effect was lost on combining pyridoxine
Authors and Affiliations
JAGMINDER KAUR BAJAJ, SATINDER JIT SINGH, PREM PARKASH KHOSLA, RANI WALIA
Keywords
Related Articles
- EP ID EP170046
- DOI 10.9735/0976-5530.3.2.115-117
- Views 113
- Downloads 0
TOXICOGENOMICS AND ITS APPLICATION IN CANCER PATHOGENESIS
Toxicology, the study of poisons, focuses on substances and treatments that cause adverse effects in living things. A critical part of this study is the characterization of the adverse effects at the level of the organis...
NECROTIZING FASCIITIS OF LOWER LIMB BY Corynebacterium striatum IN A HBsAG POSITIVE PATIENT
Corynebacteria other than C. diphtheriae are increasingly being implicated as pathogens. C. ulcerans, C. urealyticum, C. amycola-tum, C. striatum are some of the species being increasingly identified and implicated as pa...
INVESTIGATION OF MORBIDITY AND MORTALITY RATES OF CHILDREN 0-11 MONTHS IN KENEMA DISTRICT, EASTERN SIERRA LEONE: 12 MONTHS DATABASE STUDY
Objective- To investigate the 2010 reported morbidity and mortality rates for five major childhood diseases; malaria, anemia, diarrhea, acute respiratory infection (ARI) and worm infestation affecting children 0-11 month...
RISK-ADAPTED TREATMENT OF CHILDHOOD HODGKIN’S LYMPHOMA
Purpose: The comparative analysis of the efficacy and economic research of risk-adapted therapy with DAL-HD and with original protocol SPbHL-05 for childhood Hodgkin lymphoma (HL) was performed. Patients and Methods: The...
PROTEINS OF CLASSICAL AND LECTIN PATHWAY OF THE COMPLEMENT SYSTEM INVOLVED IN THE PATHOGENESIS OF RHEUMATIC HEART DISEASE
Background: Rheumatic heart disease is an inflammatory disease which predominantly affects the valvular endocardium culminating in crippling valve deformities. Inorder to find out the role of complement proteins in induc...